tiprankstipranks
TCR2 Therapeutics Inc (DE:2K7)
MUNICH:2K7

TCR2 Therapeutics (2K7) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
1Neutral
10Bearish
Technical Analysis Consensus
Buy
3Bullish
1Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
TCR2 Therapeutics Inc’s (2K7) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting TCR2 Therapeutics Inc is a Sell.
TCR2 Therapeutics Inc’s (2K7) 20-Day exponential moving average is 1.45, while TCR2 Therapeutics Inc’s (2K7) share price is €1.442, making it a Sell.
TCR2 Therapeutics Inc’s (2K7) 50-Day exponential moving average is 1.46, while TCR2 Therapeutics Inc’s (2K7) share price is €1.442, making it a Sell.

TCR2 Therapeutics (2K7) Pivot Points

Apr 30, 2024, 12:21 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.44
1.44
1.44
1.44
1.44
1.44
1.44
Fibonacci
1.44
1.44
1.44
1.44
1.44
1.44
1.44
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

TCR2 Therapeutics (2K7) Moving Averages

Apr 30, 2024, 12:21 AM
Period
Simple
Exponential
MA5
1.44Buy
1.44Sell
MA10
1.44Buy
1.44Sell
MA20
1.44Buy
1.45Sell
MA50
1.49Sell
1.46Sell
MA100
1.47Sell
1.47Sell
MA200
1.35Buy
1.56Sell
TCR2 Therapeutics Inc’s (2K7) 10-Day exponential moving average is 1.44, while TCR2 Therapeutics Inc’s (2K7) share price is €1.442, making it a Sell.
TCR2 Therapeutics Inc’s (2K7) 100-Day exponential moving average is 1.47, while TCR2 Therapeutics Inc’s (2K7) share price is €1.442, making it a Sell.
TCR2 Therapeutics Inc’s (2K7) stock price is €1.442 and TCR2 Therapeutics Inc’s (2K7) 50-day simple moving average is 1.49, creating a Sell signal.
TCR2 Therapeutics Inc’s (2K7) stock price is €1.442 and TCR2 Therapeutics Inc’s (2K7) 100-day simple moving average is 1.47, creating a Sell signal.
TCR2 Therapeutics Inc’s (2K7) stock price is €1.442 and TCR2 Therapeutics Inc’s (2K7) 200-day simple moving average is 1.35, creating a Buy signal.

TCR2 Therapeutics (2K7) Technical Indicators

Apr 30, 2024, 12:21 AM
Name
Value
Implied Action
RSI (14)
40.18
Neutral
STOCH (9,6)
<0.01
Buy
STOCHRSI (14)
>-0.01
Buy
MACD (12,26)
>-0.01
Sell
ADX (14)
5.78
Buy
CCI (14)
0.00
-
ATR (14)
<0.01
-
ROC
0.00
-
Bull/Bear Power (13)
>-0.01
Sell
TCR2 Therapeutics Inc’s (2K7) Relative Strength Index (RSI) is 40.18, creating a Neutral signal.
TCR2 Therapeutics Inc’s (2K7) Trend Strength Indicator (ADX) is 5.78, creating a Buy signal.

FAQ

Is 2K7 a Buy, Hold, or Sell?
Based on 2K7’s technical indicators, 2K7 is a Sell.
    What is 2K7’s RSI (14)?
    2K7’s RSI (14) is 40.18, which suggests 2K7 is a Neutral.
      What is 2K7’s MACD?
      2K7’s MACD is >-0.01, which suggests 2K7 is a Sell.
        What is 2K7’s 5-day moving average?
        2K7’s 5-day moving average is 1.44, which suggests 2K7 is a Buy.
          What is 2K7’s 20-day moving average?
          2K7 20-day moving average is 1.44, which suggests 2K7 is a Buy.
            What is 2K7’s 50-day moving average?
            2K7’s 50-day moving average is 1.49, which suggests 2K7 is a Sell.
              What is 2K7’s 200-day moving average?
              2K7’s 200-day moving average is 1.35, which suggests 2K7 is a Buy.
                What is 2K7’s Williams % R (14)?
                Currently, no data Available
                What is 2K7’s CCI (14)?
                Currently, no data Available
                What is the share price of TCR2 Therapeutics Inc?
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis